Skip to content

Combining Accelerometer, Gyroscope, Sound, Electrocardiography and Photoplethysmography Data in Cardiac Monitoring

Combining Accelerometer, Gyroscope, Sound, Electrocardiography and Photoplethysmography Data in Cardiac Monitoring: a Pilot Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06422468
Acronym
CARDS-pilot
Enrollment
125
Registered
2024-05-21
Start date
2024-03-21
Completion date
2024-08-01
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

Photoplethysmography, Single-lead Electrocardiography

Brief summary

The goal of this interventional clinical trial is to investigate whether combining photoplethysmography (PPG) signals with accelerometer (ACC), gyroscope (GYR), sound, and electrocardiography (ECG) derived smartphone data provides additional insights into the cardiac condition of individuals with and without atrial fibrillation (AF).

Interventions

PPG, ACC, GYR, ECG and sound measurements

Sponsors

Qompium NV
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Inclusion criteria applicable for all groups: * At least 18 years old * Participants must have the ability to understand and provide written informed consent * Participants must have the ability to understand Dutch Group specific inclusion criteria: Group 1: Healthy volunteers * No cardiac conditions based on medical history. Group 2: Cardiology patients * Patients at the consultation or ambulatory unit of Cardiology (pre- cardioversion, pre-pulmonary vein isolation) with AF. * Patients without AF but with a current cardiac condition (e.g. heart failure with a reduced or preserved ejection fraction) or a history of a cardiac condition (e.g. history of myocardial infarction).

Exclusion criteria

* Individuals with unnaturally coloured fingers (i.e. tattoos, ink); this may weaken the signal and may interfere with the effectiveness of the device * Persons with conditions causing tremors or the inability to hold their hand still for at least 60 seconds (e.g. Parkinson or dementia) as, in this case, the device may not be able to accurately process a measurement * Persons with reduced blood flow in the fingertips (e.g. perniosis or severe callus formation) as the device may not be able to detect the intensity variations induced by the blood flow * Persons that have a disability to perform the measurements according to the instructions for use * Persons with cardiac pacemakers, implantable cardioverter-defibrillators, or other implanted electronic devices as these can control the natural heart rhythm

Design outcomes

Primary

MeasureTime frameDescription
Identification of morphologic characteristics of smartphone generated signals1 dayDetect or identify specific morphologic characteristics (changes or correlations) by the comparison of PPG signals, accelerometer signals, gyroscope signals, sound signals and ECG signals, derived via the smartphone data.

Secondary

MeasureTime frameDescription
Evaluate the performance of the FibriCheck Algorithm1 dayEvaluate the performance of our PPG FibriCheck Algorithm in cardiology patients and healthy volunteers, based on simultaneously recorded ECG data (RR intervals).

Countries

Belgium

Contacts

Primary ContactLars Grieten, PhD
Lars.Grieten@fibricheck.com+3211485953
Backup ContactAnnelies Geeraerts, PhD
Annelies.Geeraerts@fibricheck.com+3211485953

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026